OTC
Strength
8.8 mg/5mL
Manufacturer
Rising Pharma Holdings Inc.NDC
57237030124
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
SENNOSIDESApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007.60On Market Since
9/27/2022
Related Drugs
Same classification
No related drugs found.